India: Dr Reddy’s to buy IP rights of Alchemia’s anti-coagulant drug for $17.5m

India: Dr Reddy’s to buy IP rights of Alchemia’s anti-coagulant drug for $17.5m

Visual sourced from Dr Reddy's website

Pramugdha Mamgain

25 September, 2015

Active Pharmaceutical IngredientAlchemia LtdAmgen Inc.anti-coagulant drugArixtraAstraZenaca PlcASXDr Reddy’sDr Reddy’s Laboratories LtdFerrer Internacional S.Afondaparinux sodiumHatchtech Pty LtdPanTheryx Inc.US Food and Drug Administration.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.